Treatment of asymptomatic bacteriuria (ASB) frequently lacks appropriate indication, yet remains prevalent across settings. Numerous guidelines, professional societies, and campaigns such as Choosing Wisely advocate against this low-value practice. Efforts aimed at reducing unnecessary treatment of ASB demonstrate improved costs, and avoidable harm without increased risk of adverse events.We propose an evidence-based implementation guide to aid practitioners in reducing inappropriate treatment of ASB.
ASJC Scopus subject areas
- Internal Medicine